HIGHLIGHTS
- who: Phosphodiesterase Type and collaborators from the Ramallah, PSE Research, Fresno Clinical Research Center, Fresno, USA Internal Medicine, Alfaisal University have published the research: Review began 07/20/2022 Review ended 08/01/2022 Published 08/03/2022 u00a9 Copyright, in the Journal: (JOURNAL) of August/03,/2022
- what: Statistical analysis was not the primary purpose of the supporting point.
- future: It is important to conduct additional prospective randomized double-blind placebo control studies with bigger sample sizes and comprehensive designs.
SUMMARY
The PDE5 inhibitors enzyme can cross the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.